| Value | ₹3.70 Cr |
|---|
BSE filing, NSE: CENTENKA. Summary written from the filing by ALFA Finder's alert engine.
Century Enka Ltd: key numbers
- Share price
- ₹446.00
- Market cap
- ₹974.5 Cr
- Revenue (annual)
- ₹1,705 Cr
- Net profit (annual)
- ₹100.8 Cr
- P/E (TTM)
- 6.8×Sector 33.3×
- Promoter holding
- 24.86%+0.00% QoQ
- FII holding
- 2.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Century Enka Ltd
All →Century Enka Business Update
Century Enka received PLI Scheme approval for the Technical Textile Segment from the Ministry of Textiles. No incentive amount was disclosed in the filing.
Century Enka Earnings Call Transcript: Key Takeaways
Revenue grew 37% but PAT fell 17% as raw material volatility and energy costs severely squeezed margins.
Century Enka Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 5,582 Mn (+36.6% YoY), PAT INR 185 Mn (-17% YoY); H1 PAT INR 802 Mn (+112.7%). Margins compressed by imports, input costs and power tariffs.
Century Enka Q2 FY27 Results: Net Profit ₹18.5 Cr, Down 17.0% YoY
Century Enka Ltd reported revenue from operations of ₹558.2 Cr (+36.6% YoY) and net profit of ₹18.5 Cr (-17.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹18.5 Cr · -17.0% YoY
Century Enka Board Meeting Date
Century Enka Ltd will hold a board meeting on 27th October 2026 to approve unaudited standalone and consolidated financial results for the quarter ended September 2026.
Century Enka Other Announcement
Century Enka Limited filed a confirmation certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Other merger & restructuring announcements
All →Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr
Saregama India Merger & Restructuring
Saregama India's board approved closing its wholly owned Dubai subsidiary, Saregama FZE, which has no ongoing operations. The closure is not expected to materially affect business operations.
Jindal Poly Films Merger & Restructuring
Jindal Poly Films' step-down subsidiary, JPF API Laminates UK Limited, was dissolved effective November 3, 2026. It has ceased to be a subsidiary of the company.